A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
Clinical trial NCT07198633 · RECRUITING
Trial details
- NCT number
- NCT07198633
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2026-12-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.